Skip to main content
. 2006 Mar 11;83(2):275–288. doi: 10.1007/s11524-005-9015-4

Table 1.

Demographic characteristics, history of injecting drug use, self-reported health status and medical care utilization of prisoners (percentages) by HCV status

Characteristics HCV Ab− HCV Ab+/non-viremic HCV Ab+/viremic P value
N = 423 N = 89 N = 178
Sex
 Male 92.2 74.2 74.7 <.001
Age (mean±SD) years 35.5 (13.7) 31.0 (8.2) 30.2 (7.6) <.001
Indigenous origin 31.9 31.5 24.2 .2
Education level*
 Nil to education with no qualification 47.0 59.6 59.0
 With qualification 51.8 39.3 39.9 .05
Employment 6 months before imprisonment*
 No 49.6 73.0 67.4
 Yes 49.9 25.8 32.0 <.001
Duration in prison
 Less than 1 year 52.3 51.7 61.2
 One or more years 47.7 48.3 38.8 .1
History of ever injecting drug use*
 No 65.5 9.0 6.7
 Yes 21.0 84.3 90.5 <.001
Duration of drug injection (median, IQR) 5 (3–9) 11 (7–16) 11 (6–16) <.001
Drug injection in prison*
 No 87.9 41.6 40.4
 Yes 7.8 49.4 55.1 <.001
Frequency of drug injection last month N = 11 N = 11 N = 26
 Daily or more 90.9 100 92.3
 Less than daily 9.1 .0 7.7 1.0
Ever told by a doctor of having hepatitis C*
 No 96.9 31.5 25.8
 Yes 1.2 66.3 71.4 <.001
Medical conditions*
 Arthritis 18.9 13.5 11.2 .1
 Respiratory disease (e.g., asthma) 17.7 32.6 20.2 .01
 Cancer 4.3 4.5 5.6 .9
 Diabetes mellitus 3.3 .0 2.8 .2
 Cardiac disease 25.8 20.2 18.5 .2
 High blood pressure 15.6 7.9 7.3 .02
 Peptic ulcer 9.9 11.2 7.3 .8
 HIV positive .3 1.2 2.4 .01
Charlson co-morbidity index score
 0–1 69.7 77.5 78.7
 >1 30.3 22.5 21.3 .05
Disabling condition lasting ≥6 months 32.4 37.1 34.8 .6
Symptoms past 4 weeks*
 None 13.7 12.4 11.8
 1–2 22.9 19.1 21.9
 3 or more 63.1 68.5 66.3 .9
Hospital admission past 12 months
 No 82.7 75.3 76.4
 Yes 17.3 24.7 23.6 .1
Depression severity(%)
 Minimal/nil (0–9) 59.8 53.9 59.6
 Mild (10–16) 23.9 25.8 15.7
 Moderate to severe (17–63) 14.4 16.9 23.6 .04

HCV Ab− HCV antibody negative prisoners, HCV Ab+/non-viremic HCV antibody positive/non-viremic prisoners; HCV Ab+/non-viremic HCV antibody positive/viremic prisoners.

*Percentages include participants who did not report.

A measurement of co-morbidity where a higher score reflects more severe co-morbidity.14

Based on Beck Depression Inventory (BDI) score.